Cathay Biotech Inc - Class A

SHSE:688065 (China)   Class A
Â¥ 48.43 (+1.02%) May 30
68.21
P/B:
2.51
Market Cap:
Â¥ 28.25B ($ 3.91B)
Enterprise V:
Â¥ 24.66B ($ 3.41B)
Volume:
72.63M
Avg Vol (2M):
2.48M
Volume:
72.63M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Cathay Biotech Inc ( SHSE:688065 ) from 2020 to May 30 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Cathay Biotech stock (SHSE:688065) PE ratio as of May 30 2024 is 68.21. More Details

Cathay Biotech Inc (SHSE:688065) PE Ratio (TTM) Chart

To

Cathay Biotech Inc (SHSE:688065) PE Ratio (TTM) Historical Data

Total 921
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 11
Cathay Biotech PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-31 68.2 2024-03-22 69.5
2024-05-30 67.5 2024-03-21 71.1
2024-05-29 67.2 2024-03-20 72.4
2024-05-28 68.1 2024-03-19 73.0
2024-05-27 69.5 2024-03-18 73.9
2024-05-24 68.8 2024-03-15 73.2
2024-05-23 68.8 2024-03-14 72.4
2024-05-22 70.7 2024-03-13 73.6
2024-05-21 70.7 2024-03-12 75.0
2024-05-20 73.1 2024-03-11 74.9
2024-05-17 72.0 2024-03-08 73.7
2024-05-16 73.0 2024-03-07 73.1
2024-05-15 75.2 2024-03-06 74.4
2024-05-14 74.2 2024-03-05 74.6
2024-05-13 75.2 2024-03-04 74.3
2024-05-10 74.9 2024-03-01 75.3
2024-05-09 75.9 2024-02-29 76.7
2024-05-08 77.9 2024-02-28 73.3
2024-05-07 77.2 2024-02-27 76.0
2024-05-06 76.7 2024-02-26 75.4
2024-04-30 72.3 2024-02-23 77.8
2024-04-29 69.2 2024-02-22 77.0
2024-04-26 61.3 2024-02-21 76.8
2024-04-25 58.0 2024-02-20 75.8
2024-04-24 56.9 2024-02-19 75.9
2024-04-23 57.3 2024-02-08 76.5
2024-04-22 57.3 2024-02-07 76.0
2024-04-19 56.5 2024-02-06 74.6
2024-04-18 56.2 2024-02-05 72.4
2024-04-17 56.6 2024-02-02 69.9
2024-04-16 54.6 2024-02-01 69.3
2024-04-15 55.8 2024-01-31 69.6
2024-04-12 52.8 2024-01-30 71.8
2024-04-11 53.3 2024-01-29 74.2
2024-04-10 54.9 2024-01-26 74.6
2024-04-09 56.5 2024-01-25 74.7
2024-04-08 56.3 2024-01-24 72.0
2024-04-03 60.5 2024-01-23 71.6
2024-04-02 61.1 2024-01-22 71.0
2024-04-01 62.1 2024-01-19 72.0
2024-03-29 62.2 2024-01-18 71.5
2024-03-28 61.4 2024-01-17 72.8
2024-03-27 69.4 2024-01-16 74.3
2024-03-26 69.9 2024-01-15 74.4
2024-03-25 68.3 2024-01-12 74.4

Cathay Biotech Inc (SHSE:688065) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Cathay Biotech Inc is engaged in production of revolutionary products, including bio-based polyamide,bio-based DN5 (1,5-pentanediamine), long chain dibasic acids (LCDA) and biobutanol. The company's commercial development platform focuses on research of molecular biology, fermentation process engineering, polymer material. Its products include Dibasic Acids, Pentamethylene Diamine, and Bio-based Polyamide.